-+ 0.00%
-+ 0.00%
-+ 0.00%

*Esperion Therapeutics: Upfront Cash Payment of $75M, Royalties on Worldwide Enbumyst Sales and Up to $180M in Potential Milestone Payments Tied to Certain Comml and Regulatory Achievements >ESPR

Dow Jones·03/03/2026 11:01:00

Please log in to view news